首页> 外文期刊>Frontiers in Chemistry >Protein disulfide isomerase expression increases in resistance arteries during hypertension development. Effects on Nox1 NADPH oxidase signaling
【24h】

Protein disulfide isomerase expression increases in resistance arteries during hypertension development. Effects on Nox1 NADPH oxidase signaling

机译:高血压发展过程中,抗动脉中的蛋白质二硫键异构酶表达增加。对Nox1 NADPH氧化酶信号转导的影响

获取原文
           

摘要

NADPH oxidases derived reactive oxygen species (ROS) play an important role in vascular function and remodeling in hypertension through redox signaling processes. Previous studies demonstrated that protein disulfide isomerase (PDI) regulates Nox1 expression and ROS generation in cultured vascular smooth muscle cells. However, the role of PDI in conductance and resistance arteries during hypertension development remains unknown. The aim of the present study was to investigate PDI expression and NADPH oxidase dependent ROS generation during hypertension development. Mesenteric resistance arteries (MRA) and thoracic aorta were isolated from 6, 8 and 12 week-old spontaneously hypertensive (SHR) and Wistar rats. ROS production (dihydroethidium fluorescence), PDI (WB, imunofluorescence), Nox1 and NOX4 (RT-PCR) expression were evaluated. Results show a progressive increase in ROS generation in MRA and aorta from 8 to 12 week-old SHR. This effect was associated with a concomitant increase in PDI and Nox1 expression only in MRA. Therefore, suggesting a positive correlation between PDI and Nox1 expression during the development of hypertension in MRA. In order to investigate if this effect was due to an increase in arterial blood pressure, pre hypertensive SHR were treated with losartan (20mg/kg/day for 30 days), an AT1 receptor antagonist. Losartan decreased blood pressure and ROS generation in both vascular beds. However, only in SHR MRA losartan treatment lowered PDI and Nox1 expression to control levels. In MRA PDI inhibition (bacitracin, 0.5 mM) decreased Ang II redox signaling (p-ERK 1/2). Altogether, our results suggest that PDI plays a role in triggering oxidative stress and vascular dysfunction in resistance but not in conductance arteries, increasing Nox1 expression and activity. Therefore, PDI could be a new player in oxidative stress and functional alterations in resistance arteries during the establishment of hypertension.
机译:NADPH氧化酶衍生的活性氧(ROS)通过氧化还原信号传导过程在高血压的血管功能和重塑中起重要作用。先前的研究表明,蛋白二硫键异构酶(PDI)调节培养的血管平滑肌细胞中Nox1的表达和ROS的产生。然而,PDI在高血压发展过程中在电导和阻力动脉中的作用仍然未知。本研究的目的是研究高血压发展过程中PDI表达和NADPH氧化酶依赖性ROS的产生。从6、8和12周龄的自发性高血压(SHR)和Wistar大鼠中分离出肠系膜阻力动脉(MRA)和胸主动脉。评估了ROS的产生(二氢乙啶荧光),PDI(WB,免疫荧光),Nox1和NOX4(RT-PCR)的表达。结果显示,从8周龄到12周龄SHR,MRA和主动脉中ROS的产生逐渐增加。仅在MRA中,这种作用与PDI和Nox1表达的伴随增加有关。因此,提示MRA高血压发展过程中PDI与Nox1表达呈正相关。为了研究这种作用是否是由于动脉血压的升高而引起的,高血压前SHR用氯沙坦(20毫克/千克/天,持续30天)治疗,这是一种AT1受体拮抗剂。氯沙坦降低了两个血管床的血压和活性氧生成。然而,仅在SHR MRA中,氯沙坦治疗可将PDI和Nox1表达降低至对照水平。在MRA中,PDI抑制(杆菌肽,0.5 mM)降低了Ang II氧化还原信号(p-ERK 1/2)。总之,我们的研究结果表明PDI在引发氧化应激和抵抗力中的血管功能障碍中起作用,但在传导性动脉中不起作用,从而增加Nox1的表达和活性。因此,PDI可能是高血压建立过程中氧化应激和抵抗动脉功能改变的新参与者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号